All News

Pharmacy team helps patients better understand importance of adherence while on complex medication regimens.

A meta-analysis of studies including almost 2 million patients finds that use of ADHD medications increases neither the risk of sudden death nor the risk of adverse cardiac events.

The FDA today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with metastatic or unresectable melanoma.

Manufacturers can use a variety of alternative distribution methods to reduce drug waste and prepare for the cost structure changes associated with health care reform.

A hypertension treatment program in which patients received online guidance from pharmacists led to improved blood pressure control even a year after the program ended.

Urban elementary school students with poorly controlled asthma tend to produce poorer schoolwork and sleep less well than those whose asthma is well-controlled.

Just 17% of children who had lived in the United States for up to 2 years had asthma or allergies, compared with 27% of those who had lived in the country for 10 years or longer.

The FDA indicated in a letter to SPAARx that future compounding legislation will omit the term "specialty pharmacy."

A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-named biologics provided that a number of criteria are met.

A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-name biologics provided that a number of criteria are met.

Planning in advance for an FDA inspection of your compounding pharmacy will help prevent rash decisions after the inspectors walk in the door.

The value of a specialty therapy lies not only in its clinical safety and efficacy, but also in how its price compares with other therapies in its class, found a new report.

United States spending on specialty prescription drugs is projected to increase 67% by the end of 2015, according to a forecast released today by Express Scripts.

The National Association of Specialty Pharmacy (NASP) announced it will host its 2013 Fall Strategic Business Exchange meeting on October 14-16, 2013 in San Antonio.

Almost three-quarters of college students say sharing prescription drugs is common among their acquaintances, and less than a fifth say their schools have established programs to deal with the problem.

The agency rejected a request from the painkiller's manufacturer to outlaw generic versions lacking tamper-resistant features just weeks after deciding the opposite way for generic versions of OxyContin.

The association between use of analgesics in infancy and increased likelihood of developing asthma may actually be due to respiratory infections that prompt analgesic use, a new study indicates.

Specialty drugs drove spend in 2012 and accounted for almost two-thirds of spending on branded products.

The FDA approved the first companion diagnostic to detect epidermal growth factor receptor (EGFR) gene mutations, which are present in approximately 10% of non-small cell lung cancers.

David Hileman, senior vice president of Omnicare, recently discussed how market access to oncology medications is changing and presented strategies manufacturers can use to support patient need through compliant distribution channels.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, celebrated its official launch at the 2013 Annual Armada Specialty Pharmacy Summit in Las Vegas, NV, on May 8, 2013